Drug Kinetics – News and Features

In lab-grown nerve cells from ALS patients, a natural compound found in certain fruits and vegetables helped the cells produce more energy and eased stress in the protein-processing center of the cell called the endoplasmic reticulum.

University of Florida scientists have helped identify a novel drug compound that selectively activates pain-altering receptors in the body, offering a potentially safer alternative to conventional pain medications such as opioids.

Oregon State University researchers have discovered a way to get anti-inflammatory medicine across the blood-brain barrier, opening the door to potential new therapies for a range of neurodegenerative diseases.

Three-dimensional models allow researchers to better represent complex tissues and cell-cell interactions. This article explores the cell models currently used by researchers to understand disease and aid drug discovery.

New findings on how the gut microbiome influences drug metabolism and effectiveness could open the door to personalized medicines and better treatment outcomes.

MIT researchers have developed a way to rapidly manufacture specialized nanoparticles that can be used for targeted delivery of cancer drugs and other therapeutics.

Drug-carrying DNA aptamers can deliver a one-two punch to leukemia by precisely targeting the elusive cancer stem cells that seed cancer relapses, researchers at the University of Illinois Urbana-Champaign report.

Discover how RNA therapeutics are reshaping medicine, offering new treatments for previously undruggable targets.

A study conducted by researchers at Hokkaido University has unveiled a novel class of zwitterionic phospholipids capable of significantly enhancing the functional delivery of mRNA.

Nitisinone, a medication typically prescribed for individuals with rare inherited diseases, has been shown to make human blood deadly to mosquitoes. It could therefore be an alternative method for controlling mosquito populations.